Applied BioCode Raises $13.2M in Public Stock Offering
Oct 31, 2018 @ 9:30

The firm will use the funds to commercialize its newly cleared molecular diagnostics platform and gastrointestinal pathogen panel test.

Sourced through Scoop.it from: www.360dx.com

Leave a Reply